Soleno Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Soleno Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About SLNO

Soleno Therapeutics, Inc. operates as clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. It focuses on the treatment of metabolic and neurobehavioral disorder. 

CEO
Anish Bhatnagar
CEOAnish Bhatnagar
Employees
92
Employees92
Headquarters
Redwood City, California
HeadquartersRedwood City, California
Founded
1999
Founded1999
Employees
92
Employees92

SLNO Key Statistics

Market cap
3.99B
Market cap3.99B
Price-Earnings ratio
-17.14
Price-Earnings ratio-17.14
Dividend yield
—
Dividend yield—
Average volume
691.21K
Average volume691.21K
High today
—
High today—
Low today
—
Low today—
Open price
$80.00
Open price$80.00
Volume
0.00
Volume0.00
52 Week high
$80.99
52 Week high$80.99
52 Week low
$36.93
52 Week low$36.93

Analyst ratings

100%

of 9 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own SLNO. This list is generated using Robinhood data, and it’s not a recommendation.
SNDL
Robinhood Markets
Plug Power
Uber
NIO
Lucid Group
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.